Quoin Pharmaceuticals announced further clinical evidence supporting the efficacy of QRX003, its topical treatment for Netherton Syndrome. Data from...

Exicure, Inc. acquired GPCR Therapeutics USA Inc. and entered into a licensing and collaboration agreement with GPCR Therapeutics Inc....

Segal Trials, a clinical research network specializing in psychiatric disorders, significantly contributed to the successful Phase 2 trial of...

ExThera Medical received funding from the Medical Technology Enterprise Consortium (MTEC) for a randomized controlled trial. The trial will...

Vaxxas, a clinical-stage biotech company, is developing a heat-stable, dried-formulation mRNA vaccine delivered via its microarray patch (HD-MAP) with...

OKYO Pharma, a clinical-stage biopharmaceutical company developing treatments for neuropathic corneal pain (NCP) and dry eye disease (DED), has...

Anthos Therapeutics announced the publication of positive results from its AZALEA-TIMI 71 study in the •New England Journal of...

Tiziana Life SciencesLife Sciences has discovered new immune biomarkers in patients with non-active secondary progressive multiple sclerosis (na-SPMS) treated...

Cullgen Inc., a clinical-stage biopharmaceutical company, has initiated human trials for CG001419, a potential first-in-class, oral, pan-TRK protein degrader...

Lisata Therapeutics announced preliminary data from Cohort A of its Phase 2 ASCEND trial evaluating certepetide, combined with standard...